Literature DB >> 20940173

High-energy phosphotransfer in the failing mouse heart: role of adenylate kinase and glycolytic enzymes.

Dunja Aksentijević1, Craig A Lygate, Kimmo Makinen, Sevasti Zervou, Liam Sebag-Montefiore, Debra Medway, Hannah Barnes, Jurgen E Schneider, Stefan Neubauer.   

Abstract

AIMS: To measure the activity of the key phosphotransfer enzymes creatine kinase (CK), adenylate kinase (AK), and glycolytic enzymes in two common mouse models of chronic heart failure. METHODS AND
RESULTS: C57BL/6 mice were subjected to transverse aortic constriction (TAC), myocardial infarction induced by coronary artery ligation (CAL), or sham operation. Activities of phosphotransfer enzymes CK, AK, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 3-phosphoglycerate kinase (PGK), and pyruvate kinase were assessed spectrophotometrically. Mice were characterized by echocardiography or magnetic resonance imaging 5- to 8-week post-surgery and selected for the presence of congestive heart failure. All mice had severe left ventricular hypertrophy, impaired systolic function and pulmonary congestion compared with sham controls. A significant decrease in myocardial CK and maximal CK reaction velocity was observed in both experimental models of heart failure. However, the activity of AK and its isoforms remained unchanged, despite a reduction in its protein expression. In contrast, the activities of glycolytic phosphotransfer mediators GAPDH and PGK were 19 and 12% higher in TAC, and 31 and 23% higher in CAL models, respectively.
CONCLUSION: Chronic heart failure in the mouse is characterized by impaired CK function, unaltered AK, and increased activity of glycolytic phosphotransfer enzymes. This pattern of altered phosphotransfer activity was observed independent of the heart failure aetiology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940173      PMCID: PMC2990411          DOI: 10.1093/eurjhf/hfq174

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  29 in total

1.  Impaired intracellular energetic communication in muscles from creatine kinase and adenylate kinase (M-CK/AK1) double knock-out mice.

Authors:  Edwin Janssen; Andre Terzic; Bé Wieringa; Petras P Dzeja
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

Review 2.  Phosphotransfer networks and cellular energetics.

Authors:  Petras P Dzeja; Andre Terzic
Journal:  J Exp Biol       Date:  2003-06       Impact factor: 3.312

3.  Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion.

Authors:  Darko Pucar; Peter Bast; Richard J Gumina; Lynette Lim; Carmen Drahl; Nenad Juranic; Slobodan Macura; Edwin Janssen; Be Wieringa; Andre Terzic; Petras P Dzeja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08       Impact factor: 4.733

4.  The sulfhydryl groups of rabbit muscle adenosine triphosphate-adenosine monophosphate phosphotransferase. Activity of enzyme treated with mercurials.

Authors:  L F Kress; V H Bono; L Noda
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

5.  Phosphotransfer dynamics in skeletal muscle from creatine kinase gene-deleted mice.

Authors:  Petras P Dzeja; Andre Terzic; Bé Wieringa
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

6.  Phosphocretine production coupled to the glycolytic reactions in the cytosol of cardiac cells.

Authors:  V V Kupriyanov; E K Seppet; I V Emelin; V A Saks
Journal:  Biochim Biophys Acta       Date:  1980-09-05

7.  31P NMR studies of ATP synthesis and hydrolysis kinetics in the intact myocardium.

Authors:  P B Kingsley-Hickman; E Y Sako; P Mohanakrishnan; P M Robitaille; A H From; J E Foker; K Uğurbil
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

Review 8.  Proteomics of heart disease.

Authors:  Emma McGregor; Michael J Dunn
Journal:  Hum Mol Genet       Date:  2003-08-19       Impact factor: 6.150

9.  Quantitative 3-dimensional echocardiography for accurate and rapid cardiac phenotype characterization in mice.

Authors:  Dana Dawson; Craig A Lygate; James Saunders; Jürgen E Schneider; Xujiong Ye; Karen Hulbert; J Alison Noble; Stefan Neubauer
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

10.  Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system.

Authors:  Jürgen E Schneider; Paul J Cassidy; Craig Lygate; Damian J Tyler; Frank Wiesmann; Stuart M Grieve; Karen Hulbert; Kieran Clarke; Stefan Neubauer
Journal:  J Magn Reson Imaging       Date:  2003-12       Impact factor: 4.813

View more
  19 in total

Review 1.  Targeting myocardial substrate metabolism in heart failure: potential for new therapies.

Authors:  Hossein Ardehali; Hani N Sabbah; Michael A Burke; Satyam Sarma; Peter P Liu; John G F Cleland; Aldo Maggioni; Gregg C Fonarow; E Dale Abel; Umberto Campia; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

2.  Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT-/- mouse hearts.

Authors:  Jelena Branovets; Mervi Sepp; Svetlana Kotlyarova; Natalja Jepihhina; Niina Sokolova; Dunja Aksentijevic; Craig A Lygate; Stefan Neubauer; Marko Vendelin; Rikke Birkedal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

3.  Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency.

Authors:  Petras P Dzeja; Kirsten Hoyer; Rong Tian; Song Zhang; Emirhan Nemutlu; Matthias Spindler; Joanne S Ingwall
Journal:  J Physiol       Date:  2011-08-30       Impact factor: 5.182

4.  LKB1/Mo25/STRAD uniquely impacts sarcomeric contractile function and posttranslational modification.

Authors:  Samantha M Behunin; Marissa A Lopez-Pier; Camille L Birch; Laurel A K McKee; Christiane Danilo; Zain Khalpey; John P Konhilas
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

5.  Liver Kinase B1 complex acts as a novel modifier of myofilament function and localizes to the Z-disk in cardiac myocytes.

Authors:  Samantha M Behunin; Marissa A Lopez-Pier; Rachel M Mayfield; Christiane A Danilo; Yulia Lipovka; Camille Birch; Sarah Lehman; Jil C Tardiff; Carol C Gregorio; John P Konhilas
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

Review 6.  Cardiac metabolism in hypertrophy and heart failure: implications for therapy.

Authors:  N Siddiqi; S Singh; R Beadle; D Dawson; M Frenneaux
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

7.  Sensitivity analysis of flux determination in heart by H₂ ¹⁸O -provided labeling using a dynamic Isotopologue model of energy transfer pathways.

Authors:  David W Schryer; Pearu Peterson; Ardo Illaste; Marko Vendelin
Journal:  PLoS Comput Biol       Date:  2012-12-06       Impact factor: 4.475

8.  Chronic creatine kinase deficiency eventually leads to congestive heart failure, but severity is dependent on genetic background, gender and age.

Authors:  Craig A Lygate; Debra J Medway; Philip J Ostrowski; Dunja Aksentijevic; Liam Sebag-Montefiore; Imre Hunyor; Sevasti Zervou; Jurgen E Schneider; Stefan Neubauer
Journal:  Basic Res Cardiol       Date:  2012-07-04       Impact factor: 17.165

9.  Increases in the risk of cognitive impairment and alterations of cerebral β-amyloid metabolism in mouse model of heart failure.

Authors:  Xiaoqi Hong; Liping Bu; Yi Wang; Jing Xu; Jian Wu; Yufang Huang; Jie Liu; Haiyun Suo; Lumeng Yang; Yuncen Shi; Yi Lou; Zhengliang Sun; Guoqi Zhu; Thomas Behnisch; Mei Yu; Jianguo Jia; Wangxi Hai; Hongping Meng; Sheng Liang; Fang Huang; Yunzeng Zou; Junbo Ge
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

10.  A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis.

Authors:  Sevasti Zervou; Tanmoy Ray; Natasha Sahgal; Liam Sebag-Montefiore; Rebecca Cross; Debra J Medway; Philip J Ostrowski; Stefan Neubauer; Craig A Lygate
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-28       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.